News Sentiment

GDRX sentiment intelligence

Goodrx Holdings Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 57 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Health Information Services Read-through group
Latest close 2.95 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 57

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-3.3% over one week, +11.3% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

Stocks making big moves yesterday: RXO, Progyny, Cigna, GoodRx, and Domino's

Market Reaction

Balanced read

60/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction -3.3% Price reacting lower
Trend fit Trend active 11.3% over four weeks
Fair value -41.6% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 45
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 57
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 20
Market source 14
simplywall.st 5
Sahm 5
Business Wire 2
The Motley Fool 2
StockStory 1
TradingView 1

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 18
Balance sheet 4
Analyst action 3
Deals and strategy 2
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-57 of 57
Sahm Direct company coverage

Why Jim Cramer Says 'Pull The Trigger' On Chevron

Jim Cramer recommends buying Chevron (CVX) due to its strong cash flow, 3.8% yield, and the fact that its stock was significantly higher the last time oil prices were at current levels. He also commented on GoodRx, Vertiv, and Sterling Infrastructure, advising caution for the lat

Tone
Neutral 50/100
Event
Balance sheet
Published
13 May 2026 21:09
Source
Sahm
Stock Titan Direct company coverage

GoodRx (GDRX) awards 54,494 RSUs to Chief Accounting Officer Thomas Chan

GoodRx Holdings, Inc. has granted 54,494 restricted stock units (RSUs) to its Chief Accounting Officer, Thomas Chan. These RSUs represent a contingent right to receive one share of Class A common stock each. The award will vest in 1/12 increments quarterly, beginning on August 15

Tone
Neutral 50/100
Event
Market update
Published
12 May 2026 23:09
Source
Stock Titan
Stock Titan Direct company coverage

GDRX (NASDAQ: GDRX) Form 144 — 43,100-share proposed sale

Morgan Stanley Smith Barney LLC Executive Financial Services has filed a Form 144 to report a proposed sale of 43,100 shares of Common stock for GoodRx Holdings, Inc. (NASDAQ: GDRX). The shares are comprised of two restricted stock lots dated June 3, 2025 (25,852 shares) and July

Tone
Neutral 50/100
Event
Market update
Published
12 May 2026 14:40
Source
Stock Titan
Sahm Direct company coverage

GoodRx Holdings (GDRX) Thin Q1 Profit Margins Test Bullish Earnings Growth Narratives

GoodRx Holdings (GDRX) reported Q1 2026 revenue of US$194.0 million and basic EPS of US$0.00, with trailing net profit margins at 2.6%. Despite analyst forecasts for 26.2% earnings growth, current thin margins, a one-off US$18.7 million loss, and a high P/E ratio compared to peer

Tone
Negative 34/100
Event
Earnings
Published
09 May 2026 02:09
Source
Sahm
Business Wire Direct company coverage

GoodRx Reports First Quarter 2026 Results

GoodRx Holdings, Inc. announced its financial results for the first quarter of 2026, reporting revenue of $194.0 million and net income of $1.2 million. While overall revenue decreased by 4% year-over-year, its Pharma Direct revenue saw an 82% increase, and subscription revenue g

Tone
Positive 71/100
Event
Earnings
Published
08 May 2026 02:09
Source
Business Wire
Stock Titan Direct company coverage

GoodRx (NASDAQ: GDRX) Q1 2026 shifts from Rx volume to Pharma Direct growth

GoodRx Holdings, Inc. (NASDAQ: GDRX) reported a shift in revenue composition for Q1 2026, with overall revenue slightly decreasing to $194.0 million from $203.0 million year-over-year. The core prescription transactions business saw a 24% decline, attributed to fewer Monthly Acti

Tone
Negative 40/100
Event
Earnings
Published
07 May 2026 06:10
Source
Stock Titan
Stock Titan Direct company coverage

GoodRx (NASDAQ: GDRX) grows Pharma Direct and lifts 2026 outlook

GoodRx reported Q1 2026 revenue of $194.0 million, a 4% decrease year-over-year, largely due to a 24% decline in prescription transactions revenue. However, Pharma Direct revenue surged 82% to $52.2 million, and subscription revenue increased 16% to $24.4 million, reflecting a st

Tone
Positive 60/100
Event
Earnings
Published
07 May 2026 03:10
Source
Stock Titan
Stock Titan Direct company coverage

GoodRx (NASDAQ: GDRX) CAO Thomas Chan reports stock, options and RSUs

GoodRx Holdings, Inc. Chief Accounting Officer Thomas Chan has filed an initial ownership report (Form 3) detailing his holdings in the company. The filing indicates direct ownership of 1,000 Class A common shares, multiple stock options with varying exercise prices and expiratio

Tone
Neutral 50/100
Event
Market update
Published
01 May 2026 21:39
Source
Stock Titan
Stock Titan Direct company coverage

Executive pay, auditor change headline GoodRx (NASDAQ: GDRX) 2026 vote

GoodRx Holdings, Inc. (NASDAQ: GDRX) is holding its 2026 virtual Annual Meeting of Stockholders on June 16, 2026. Key agenda items include the election of three Class III directors, the ratification of KPMG LLP as the independent registered public accounting firm, and an advisory

Tone
Neutral 50/100
Event
Market update
Published
30 Apr 2026 11:09
Source
Stock Titan
Sahm Direct company coverage

What's Going On With GoodRx Stock Thursday?

GoodRx Holdings, Inc. (NASDAQ: GDRX) shares are gaining premarket following the announcement of expanding access to Eli Lilly and Company’s (NYSE: LLY) new oral GLP-1 medication, Foundayo, starting at $149 per month. The company is also expanding access to Zepbound, available sta

Tone
Neutral 50/100
Event
Market update
Published
28 Apr 2026 02:09
Source
Sahm
The Motley Fool Direct company coverage

How Does GoodRx Make Money?

Tone
Neutral 50/100
Event
Market update
Published
18 Oct 2025 07:00
Source
The Motley Fool